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SUMMARY – The aim of the study was to show the role of tools in the evaluation of chronic 
pain (CP) in general practitioner (GP) everyday clinical practice. The study was done by analyzing 
electronic database of the first visits of 1090 CP patients referred to the Pain Clinic of the Karlovac 
General Hospital, Karlovac, Croatia, by their GPs. All patient records were analyzed according to 
the cause of CP, strongest pain a week before the examination, quality of sleep, and the Patients’ 
Global Impression of Change scale. All statistical analyses were done using the IBM SPSS Stati-
stics version 19.0.0.1 (www.spss.com). CP predominantly occurs in older age group. Patients with 
musculoskeletal pain accounted for the highest percentage (n=316; 29%), followed by those with 
neuropathic pain (n=253; 23.20%) and those with low back pain (n=225; 20.60%). The mean pain 
intensity rating scale score was 8.3±1.8 a week before the examination and the mean quality of sleep 
score was 6.8±1.9. Moderate and severe sleep quality disorder was significantly present in patients 
over 65 years of age (p=0.007), patients with musculoskeletal and neuropathic pain, back pain, and 
those having rated Patients’ Global Impression of Change scale as worsening (p=0.001). The severity 
of pain and poor quality of sleep are the leading causes of deterioration of the Patients’ Global Im-
pression of Change scale in patients suffering from musculoskeletal and neuropathic pain. In order 
to treat CP comprehensively, it is important for GPs to evaluate the outcomes of clinical treatment 
using tools for CP assessment.
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Introduction
Chronic pain (CP) has a major impact on physical, 
emotional and cognitive function, on social and fam-
ily life, and on the ability to work1. CP of moderate to 
severe intensity occurs in 19% of adult Europeans, se-
riously affecting the quality of their social and work-
ing lives2-4. Common chronic pain conditions affect a 
large percentage of the population in both developed 
and developing countries of the world5. Additional-
ly, CP combined with increased mortality requires a 
deeper look at it as a public health problem4. 
The majority of patients with CP are treated by 
their general practitioner (GP). Only a small percent-
age is under the care of pain specialists6. Therefore, it 
is of extreme importance for GPs to be able to apply 
unique therapeutic guidelines and evaluate the effect 
of applied therapy in their patients. Numerous studies 
indicate the need of changes in the treatment of CP in 
family medicine7-10.
Comprehensive evaluation of any chronic pain 
condition requires complete history of the pain, 
physical examination, specific diagnostic tests, and 
the application of chronic pain assessment tools11,12. 
Pain assessment is the basis of clinical research and 
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effective treatment of pain. The Initiative on Meth-
ods, Measurement, and Pain Assessment in Clinical 
Trials recommendations (IMMPACT) are primar-
ily recommendations for improving the methodology 
of clinical trials. Having outcome measures that are 
practical enough to be applied to all patients is also 
important for everyday clinical practice. These mea-
sures should be comprehensive in order to be used 
in the evaluation of the patient’s complaints and the 
physician’s recommendations11. Pain intensity rating, 
quality of sleep, and patient ratings of improvement 
or worsening of the pain condition using the Patients’ 
Global Impression of Change scale (PGIC) are all 
parts of the recommended tools to evaluate chronic 
pain. Despite the above, the fact is that these mea-
sures are very rarely used by GPs in their everyday 
clinical practice, but are mainly used as part of clinical 
trials. Not only do pain scales provide a recognized 
and validated method for tracking changes in pain in-
tensity and the effectiveness of treatments, but they 
will also signal to the patient that the pain is taken 
seriously. The research by Breivik et al.2 from 2006 
showed that only 9% of respondents confirmed that 
their doctor used a pain scale.
Sleep disturbance is perhaps one of the most com-
mon complaints of patients with chronic pain condi-
tions. Experimental studies of healthy persons and 
cross-sectional studies of clinical populations suggest 
the possibility that the interaction between sleep dis-
turbances and pain is reciprocal, so that pain disrupts 
the continuity and quality of sleep, and poor sleep 
exacerbates the pain13,14. Various instruments are ef-
fective for measuring sleep disorders. Among the in-
struments used in clinical trials to examine sleep dis-
turbances in patients with pain, the Pittsburgh Sleep 
Quality Index (PSQI) and the Medical Outcomes 
Study (MOS) sleep scale may be the best choice15. 
The sleep quality numerical rating scale can be used in 
everyday clinical practice. Assessment of the complete 
quality of sleep can be estimated by using this scale, 
and it is often employed to evaluate analgesic effects in 
patients with fibromyalgia15.
The PGIC scale is recommended by IMMPACT 
for use in studies of chronic pain as a basic measure of 
global improvement in treatment. PGIC enables sen-
sitive and easily-evaluated patient estimates in terms 
of the importance of deterioration and improvement. 
Respondents use this scale with seven possible answers 
(a seven-point rating scale): very significant improve-
ment, significant improvement, minimal improve-
ment, no change, minimal deterioration, significant 
deterioration, and very significant deterioration12. 
The aim of our study was to show the role of tools 
in the evaluation of chronic pain (PI-NRS, single-
item Sleep Quality Numerical Rating Scale, PGIC) 
in everyday clinical practice of GPs, their influence on 
the assessment of therapeutic effect, and the possible 
need of change in therapeutic strategy. The secondary 
objective was to investigate the mutual effect of pain 
intensity and quality of sleep in the PGIC in certain 
groups of CP patients.
Patients and Methods
The study was done by analyzing the electronic da-
tabase of the first examination of all patients treated at 
the Clinic for Pain and Palliative Medicine, Karlovac 
General Hospital in the period from September 24, 
2008 to December 8, 2011. All patients were referred 
by their GPs due to chronic pain of malignant or be-
nign origin. The research was given approval by the 
local ethics committee. Karlovac General Hospital is 
a county hospital in the Republic of Croatia with a 
catchment population of about 70,000. The propor-
tion of people aged 65 and over in the total population 
of Karlovac County is 19.93% (15.62% in Croatia), 
and Karlovac County ranks among the counties with 
the oldest population in Croatia. Seventy-six teams of 
family physicians provide care for the given popula-
tion. 
The analysis included a total of 1090 patients. Data 
on the age, gender, and diagnosis of CP condition were 
collected and analyzed for each patient. Following the 
initial diagnoses by family physicians, patients were 
divided into five groups, as follows: musculoskeletal 
pain, headaches, neuropathic pain, low back pain, and 
malignant pain. In order to evaluate the effectiveness 
of previous therapy, the strongest pain a week prior to 
the examination was recorded at the initial examina-
tion, as well as the quality of sleep and PGIC. All 
analyzed data are required parts of the patient medical 
records collected by our outpatient clinic personnel.
The severity of chronic pain was measured using 
a numerical scale for pain on an 11-point numerical 
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pain intensity rating scale (PI-NRS), where 0 means 
no pain and 10 the worst possible pain. Taking into 
account the PI-NRS, patients were divided into four 
groups, as follows: no pain (0), mild pain (1-3), medi-
um-severe pain (4-6), and very strong pain (7-10). A 
single-item scale was used to assess the overall qual-
ity of sleep. Patients reported the quality of their sleep 
on an 11-point numerical rating scale ranging from 
0 (best possible sleep) to 10 (worst possible sleep). 
Given the quality of sleep, patients were divided into 
four groups, as follows: no sleep disturbances (0), mild 
sleep disturbance (1-3), mild to moderate sleep distur-
bance (4-6), and very strong sleep disturbance (7-10). 
The PGIC scale was recorded as the primary measure 
of global improvement of the applied treatment by the 
GP. This seven-answer scale (seven-point rating scale) 
is applied in everyday clinical practice in our surgery, 
but is divided into the following three categories: im-
provement, deterioration, and no change.
Data are shown in tables. Data distribution was 
analyzed using the Smirnov-Kolmogorov test and ap-
propriate parametric tests, and descriptive statistics 
were used in succeeding analyses. Means and standard 
deviations were used to describe quantitative variables 
and frequencies, with overall percentage for categori-
cal values. Between-group differences according to the 
quality of sleep were analyzed by the c2-test. Pearson 
correlation coefficients were calculated between PGIC 
scores and other clinical scores. All p values below 
0.05 were considered significant. All statistical analy-
ses were done using the IBM SPSS Statistics version 
19.0.0.1 (www.spss.com). 
Table 1. General descriptive statistics in study sample (N=1090)
Gender
Male: n (%) 376 34.50%
Female: n (%) 714 65.50%
PGIC
Deterioration: n (%) 521 47.80%
Without changes: n (%) 380 34.90%
Improvement: n (%) 6 0.60%
Missing: n (%) 183 16.80%
Diagnosis
Musculoskeletal pain: n (%) 316 29.00%
Headaches: n (%) 138 12.70%
Neuropathic pain: n (%) 253 23.20%
Low back pain 225 20.60%
Malignant pain 158 14.50%
PI-NRS No pain: n (%) 0 0.00%
groups Mild pain: n (%) 11 1.00%
  Secondary severe pain: n (%) 176 16.10%
  Very strong pain: n (%) 848 77.80%
  Missing: n (%) 55 5.00%
Quality of sleep
Without sleep disturbances: n (%) 0 0.00%
A slight disorder: n (%) 68 6.20%
Medium strong disorder: n (%) 244 22.40%
Very strong disorder: n (%) 627 57.50%
Missing: n (%) 151 13.90%
Age (yrs) Mean ± SD 62.3 ±15.3
PI-NRS Mean ± SD 8.3 ±1.8
Quality of sleep Mean ± SD 6.8 ±1.9
PGIC = Patients’ Global Impression of Change; PI-NRS = numerical scale for pain on an 11-point 
numerical pain intensity rating scale; Quality of sleep on an 11-point numerical rating scale
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Results
Table 1 shows general descriptive statistics of the 
sample of 1090 patients. In the examined sample, 
there were 714 (65.50%) women and 376 (34.50%) 
men, mean age 62.3±15.3 years. The most common 
reason for referral to a pain clinic by the GP was mus-
culoskeletal pain in 316 (29.00%), neuropathic pain 
in 253 (23.20%), low back pain in 225 (20.60%), ma-
lignant pain in 158 (14.50%) and headache in 138 
(12.70%) patients.
The mean strongest pain a week prior to the ex-
amination (PI-NRS) was 8.3±1.8. Eight hundred 
and forty-eight (77.80%) patients graded it as very 
strong pain, 176 (16.10%) as medium-severe pain and 
11 (1.00%) as mild pain. Data on the severity of pain 
were missing for 55 (5.00%) patients. 
The mean quality of sleep on the 11-point numeri-
cal rating scale was 6.8±1.9. Very strong quality of 
sleep disorder was present in 627 (57.50%), medium to 
mild in 244 (22.40%), and mild in 68 (20.6%) patients. 
None of the patients was free from sleep quality dis-
ruption. The overall improvement over therapy previ-
ously administered by their family doctor (PGIC) was 
rated as improved by 0.60%, no change by 34.90% and 
deteriorated by 47.80% of patients. Data were missing 
for 16.80% of patients. 
Table 2 shows comparison of the values measured 
in groups with sleep quality disorder and categori-
cal values (c2-test with Yates correction). It is clear 
that medium-strong and strong sleep quality disor-
ders were not significantly more present in females 
(p=0.069), but had a higher incidence in the >65 age 
group (p=0.007). Patients who rated their PGIC as 
Table 2. Comparison of measured values according to groups with sleep quality disorders (c2-test)
 
Quality of sleep group
pMild disorder
Medium-strong 
disorder Very strong disorder
N=68 N=244 N=627
n % n % n %
Gender
Male 32 47.10 78 32.00 218 34.80
0.069
Female 36 52.90 166 68.00 409 65.20
Age: 
groups
<45 14 20.60 31 12.70 89 14.20
0.007
45-55 22 32.40 48 19.70 102 16.30
55-65 11 16.20 46 18.90 145 23.10
>65 21 30.90 119 48.80 291 46.40
PGIC1*
Deterioration 28 45.90 129 60.60 340 58.90
0.001Without changes 31 50.80 80 37.60 237 41.10
Improvement 2 3.30% 4 1.90 0 0.00
Diagnosis
Musculoskeletal pain 19 27.90 73 29.90 186 29.70
0.008
Headaches 19 27.90 25 10.20 68 10.80
Neuropathic pain 12 17.60 64 26.20 152 24.20
Low back pain 8 11.80 52 21.30 136 21.70
Malignant pain 10 14.70 30 12.30 85 13.60
PI-NRS
No pain 0 0.00 0 0.00 0 0.00
0.140
Mild pain 2 2.90 2 0.80 6 1.00
Medium severe pain 5 7.40 42 17.30 111 17.70
Very strong pain 61 89.70 199 81.90 509 81.30
*Missing data on 183 patients; PGIC = Patients’ Global Impression of Change; PI-NRS = numerical scale for pain on an 11-point 
numerical pain intensity rating scale; Quality of sleep on an 11-point numeric rating scale
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aggravated had a significantly worse sleep quality 
(p=0.001) compared to those whose PGIC was rated 
as an improvement or no change. Medium-strong 
and severe sleep disturbance was more common in 
patients with musculoskeletal pain, neuropathic pain 
and back pain, whereas patients with headache had 
mild sleep disorder. The severity of pain did not af-
fect the severity of sleep quality disorders. All patients 
with severe pain complained equally of all categories 
of sleep quality disorders. 
Table 3 shows correlation of strongest measured 
pain scores and sleep with PGIC compared to diag-
nosis by Pearson correlation coefficient. There was a 
significant negative correlation between the strongest 
measured pain (r=-0431, p<0.001) and sleep scores 
(r=-0230, p<0.001) with PGIC in musculoskeletal 
pain. A significant negative correlation between the 
strongest measured pain (r=-0336, p<0.001) and sleep 
score (r=-0230, p<0.001) with PGIC was found in 
neuropathic pain. A significant negative correlation 
between the intensity of pain and PGIC was found 
for low back pain (r=-0390, p<0.001) and malig-
nant pain (r=-0445, p<0.001), whereas there was no 
significant correlation with the quality of sleep and 
PGIC for these diagnoses. There was no correlation 
between headaches and PI-NRS and quality of sleep 
with PGIC.
Discussion 
Our study showed that chronic pain usually oc-
curred in older age groups. The mean age of our pa-
tients was 62.3±15.3 years, which was somewhat 
higher than the age analyzed in other studies avail-
able2,5,16. The reason for this is probably the older age 
structure in our county. Likewise, CP was more com-
mon in women (65.50%), which is comparable with 
the literature2,5. Considering the causes of CP, in our 
patients the most common one was musculoskeletal 
pain (29.00%), followed by neuropathic pain (23.20%) 
and low back pain (20.60%). These results are consis-
tent with the research by Sjøgren et al.17, which showed 
the musculoskeletal pain (66.8%) to be the most com-
mon cause of CP conditions. However, Tsang et al.5 
concluded that common pain conditions affected a 
large percentage of people in both developed and de-
Table 3. Correlations of the strongest measured pain and quality of sleep with PGIC compared with diagnosis (Pear-
son correlation coefficients)
Diagnosis     PI-NRS Quality of sleep
Musculoskeletal pain PGIC








Pearson correlation -0.366 -0.198
p <0.001 0.004
n 221 210
Low back pain PGIC




Pearson correlation -0.445 -0.140
p <0.001 0.145
n 116 110
PGIC = Patients’ Global Impression of Change; PI-NRS = numerical scale for pain on an 11-point numerical pain intensity rating scale; 
Quality of sleep on an 11-point numeric rating scale
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veloping countries, and back pain and headache were 
most common, with a higher incidence of CP condi-
tions in women and older age groups. The mean stron-
gest pain a week before the examination (PI-NRS) in 
our patients was 8.3±1.8. Very strong pain after the 
treatment administered by the GP was described by 
77.80% of patients. Breivik et al.2 report on one of five 
adult Europeans on average to suffer from CP, which 
is moderate in two-thirds and severe in one-third of 
cases. This suggests substantial underestimation in 
the treatment of CP in family medicine, poor thera-
peutic approach, and the need of education in the use 
of treatment guidelines and tools to evaluate CP. 
Many studies indicate a connection between CP 
and sleep quality13,18,19. Among the many symptoms 
associated with pain, significant sleep disorder is one 
of the most common. It occurs in at least 50% of CP 
patients. Sleep disorder involves a combination of 
problems in initiating sleep, as well as maintenance 
or benefit of sleep. There is considerable evidence that 
inadequate sleep contributes to pain and vice versa. 
The fact is that the treatment of pain in clinical tri-
als is combined with reduction of insomnia, daytime 
sleepiness, and suffering15. Sleep disorder has a bidi-
rectional relationship with other features of CP. Pre-
vious clinical studies suggest that sleep and rest are 
frequently disturbed in patients with CP. Up to 88.9% 
of patients had at least one problem with sleep. Dis-
ruption of sleep correlates with stronger pain, depres-
sion, disability, and physical symptoms19,20. 
In order to evaluate the complete quality of sleep, 
we used a single-item sleep quality numerical rating 
scale in our study. Easy applicability makes it a suitable 
tool to evaluate the quality of sleep in everyday clinical 
practice. All our subjects had a sleep quality disorder. 
The mean quality of their sleep on an 11-point numer-
ical rating scale was 6.8±1.9. Very strong disorder in 
the quality of sleep was present in 627 (57.50%), me-
dium-strong in 244 (22.40%), and mild in 68 (20.6%) 
patients. Disruption of sleep quality was significantly 
present in patients aged over 65 (p=0.007), those with 
musculoskeletal pain, neuropathic pain, back pain, 
and those who had their PGIC evaluated as deterio-
rating (p=0.001). These data indicate the need of strat-
egies in the treatment of CP, which should include 
evaluation and treatment of sleep quality correlated 
with age, gender, and the cause of CP. Goral et al.14 
have shown that chronic pain itself, or as a comorbid-
ity with depressive and anxiety disorders, is associated 
with increased likelihood of sleep problems. Patients 
with CP have a two- to three-fold greater likelihood 
of sleep problems than those who do not suffer from 
CP or psychiatric disorders. The strong association of 
pain, depression, anxiety symptoms and sleep disor-
ders suggests that some patients with pain require a 
comprehensive strategy with the aim of treating all 
three problems. Available clinical trials indicate that 
a significant number of patients who suffer from CP 
are not pleased with their examination, diagnosis, or 
treatment methods offered2,17. The PGIC is recom-
mended by IMMPACT for use in the research on 
chronic pain as a basic measure of global improve-
ments in treatment, or as the main outcome measure 
of global improvement in therapy12. Even using this 
tool to evaluate CP, 47.80% of our respondents esti-
mated PGIC on ‘previously conducted therapy with 
your GP’ as aggravation. 
It is the effectiveness of therapy, as well as the satis-
faction of patients, which are considered essential out-
comes of CP treatment. Correlation coefficients have 
shown that the PGIC is under strong negative im-
pact of pain intensity in patients with musculoskeletal 
pain, neuropathic pain, low back pain, and malignant 
pain. That is, the absence of pain is one of the leading 
causes of PGIC worsening and, with headaches, there 
is no link between the PI-NRS and quality of sleep 
with PGIC. This supports the concept that the level of 
pain is the leading component of the global response 
of patients that integrates the effect of therapy (treat-
ment), side effects, and patient expectations.
This concept was also proven by Farrar and 
Young21. Data collected from 2724 patients from 
10 placebo-controlled clinical trials of pregabalin in 
diabetic polyneuropathy, post-herpetic neuralgia, low 
back pain, fibromyalgia, and osteoarthritis showed 
close correlation between changes in PI-NRS and 
the PGIC. These serve as an information that facili-
tates comparison of results between studies, but also 
helps determine the value of a given therapy in clini-
cal practice. Equally so, by using Pearson correlation 
coefficient in our results, we showed the PGIC as a 
global outcome measure of improvements in therapy 
to be under strong negative impact of poor quality 
of sleep in patients with musculoskeletal and neuro-
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pathic pain. There are only a small number of clinical 
trials showing that the experience of pain and other 
comorbid symptoms affects PGIC21,22. In a study in-
vestigating the interaction between changes in pain, 
depressive mood, physical function, vitality, sleep dis-
orders, cognitive complaints, and PGIC in 1260 par-
ticipants with fibromyalgia who had completed one of 
two clinical trials of safety and efficacy of milnacip-
ran, Geisser et al.22 demonstrated a very strong corre-
lation between changes in clinical status and PGIC in 
many of these relationships. Therefore, it is likely that 
changes in other symptoms, along with pain percep-
tion, contribute to global improvement because of the 
intervention. The authors’ findings suggest that the 
perception of improved clinical status is largely made 
up of a set of clinical parameters out of which pain is 
the most important.
Conclusion
Chronic pain is a disorder commonly encountered 
by the GPs, and the aging of the population will re-
sult in an increased prevalence of this diagnosis. For 
a comprehensive approach to treating CP by GPs, to-
gether with the application of clinical guidelines, it 
is important that clinicians evaluate clinical outcomes 
of treatment in a standardized framework. Tools to 
evaluate CP in daily clinical practice must be practi-
cal enough to evaluate everything the patients report 
and to provide clinicians with a comprehensive thera-
peutic approach. Subsequent studies should evaluate 
those most applicable for the treatment of CP in fam-
ily medicine.
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Sažetak
PRIKLADNI ALATI ZA PROCJENU KRONIČNE BOLI U KLINIČKOJ PRAKSI 
M. Lončarić-Katušin, M. Milošević, A. Žilić, P. Mišković, V. Majerić-Kogler i J. Žunić
Cilj istraživanja bio je pokazati ulogu alata za procjenu kronične boli u svakodnevnoj kliničkoj praksi obiteljskog li-
ječnika. Istraživanje je provedeno analizom elektroničke baze podataka prvog pregleda 1090 bolesnika s kroničnom boli 
upućenih od obiteljskog liječnika u Ambulantu za bol Opće bolnice Karlovac, Karlovac, Hrvatska. Za sve bolesnike anali-
zirani su uzrok kronične boli, najjača bol tjedan dana prije pregleda, kvaliteta sna i ljestvica općeg dojma bolesnika o pro-
mjeni. Statistička analiza je učinjena pomoću programa IBM SPSS Statistics ver. 19.0.0.1 (www.spss.com). Kronična bol 
se pretežito javlja u starijoj dobnoj skupini. Najzastupljeniji su bili bolesnici s mišićno-koštanom boli (n=316; 29%), potom 
oni s neuropatskom boli (n=253; 23,20%) i oni s bolnim leđima (n=225; 20,60%). Srednja najjača bol (Pain Intensity Rating 
Scale, PI-NRS) tjedan dana prije pregleda bila je 8,3±1,8, a kvaliteta sna 6,8±1,9. Srednje jaki i jaki poremećaj kvalitete sna 
značajnije je prisutan kod bolesnika iznad 65 godina starosti (p=0,007), bolesnika s mišićno-koštanom, neuropatskom boli 
i bolnim leđima te onih koji su prema ljestvici općeg dojma bolesnika o promjeni ocijenili kao pogoršanje (p=0,001). Jačina 
boli i loša kvaliteta sna bili su vodeći uzrok pogoršanja prema ljestvici općeg dojma bolesnika o promjeni za bolesnike koji 
boluju od mišićno-koštane i neuropatske boli. Radi sveobuhvatnog liječenja važno je da obiteljski liječnici procijene ishode 
kliničkog liječenja alatima za procjenu kronične boli. 
Ključne riječi: Kronična bol; Obiteljska medicina; Bol, mjerenje; San
